Integrating tobacco control into China's health management: Strategies for healthier China.
作者信息
Xiao Dan, Wang Chen
机构信息
Department of Tobacco Control and Prevention of Respiratory Disease, China Japan Friendship Hospital, WHO Collaborating Center for Tobacco Cessation and Respiratory Diseases Prevention, National Respiratory Medical Center, China National Clinical Research Center for Respiratory Diseases, Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing 100029, China.
Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China.
出版信息
Chin Med J Pulm Crit Care Med. 2024 Oct 18;2(4):211-213. doi: 10.1016/j.pccm.2024.08.005. eCollection 2024 Dec.
Abstract
摘要
相似文献
1
Integrating tobacco control into China's health management: Strategies for healthier China.将烟草控制纳入中国的健康管理：建设健康中国的策略
Chin Med J Pulm Crit Care Med. 2024 Oct 18;2(4):211-213. doi: 10.1016/j.pccm.2024.08.005. eCollection 2024 Dec.
2
British American Tobacco's tactics during China's accession to the World Trade Organization.英美烟草在中国加入世界贸易组织期间的策略。
Tob Control. 2007 Apr;16(2):133-7. doi: 10.1136/tc.2006.018374.
3
Using an evidence-based safety approach to develop China's road safety strategies.运用循证安全方法制定中国道路安全战略。
J Glob Health. 2019 Dec;9(2):020602. doi: 10.7189/jogh.09.020602.
4
Advancing knowledge of One Health in China: lessons for One Health from China's dengue control and prevention programs.推进中国的“同一健康”知识：中国登革热防控项目对“同一健康”的启示
Sci One Health. 2024 Nov 8;3:100087. doi: 10.1016/j.soh.2024.100087. eCollection 2024.
5
Expanding public health in China: an empirical analysis of healthcare inputs and outputs.中国公共卫生的扩展：医疗投入与产出的实证分析。
Public Health. 2017 Jan;142:73-84. doi: 10.1016/j.puhe.2016.10.007. Epub 2016 Nov 22.
6
Understanding China's growing involvement in global health and managing processes of change.了解中国在全球卫生领域日益增加的参与度以及管理变革进程。
Global Health. 2020 May 1;16(1):39. doi: 10.1186/s12992-020-00569-0.
7
China's health assistance to Africa: opportunism or altruism?中国对非洲的卫生援助：是机会主义还是利他主义？
Global Health. 2016 Dec 3;12(1):83. doi: 10.1186/s12992-016-0217-1.
8
The challenge of healthcare big data to China's commercial health insurance industry: evaluation and recommendations.医疗大数据对中国商业健康保险行业的挑战：评估与建议。
BMC Health Serv Res. 2022 Sep 22;22(1):1189. doi: 10.1186/s12913-022-08574-2.
9
China's position in negotiating the Framework Convention on Tobacco Control and the revised International Health Regulations.中国在《烟草控制框架公约》和《国际卫生条例（修订版）》谈判中的立场。
Public Health. 2014 Feb;128(2):161-6. doi: 10.1016/j.puhe.2013.08.003. Epub 2013 Dec 25.
10
Analysis of the structure and trend prediction of China's total health expenditure.分析中国卫生总费用的结构和趋势预测。
Front Public Health. 2024 Sep 24;12:1425716. doi: 10.3389/fpubh.2024.1425716. eCollection 2024.
引用本文的文献
1
Arylsulfatase K attenuates airway epithelial cell senescence in COPD by regulating parkin-mediated mitophagy.芳基硫酸酯酶K通过调节帕金蛋白介导的线粒体自噬减轻慢性阻塞性肺疾病中的气道上皮细胞衰老。
Redox Biol. 2025 Jul 31;86:103793. doi: 10.1016/j.redox.2025.103793.
本文引用的文献
1
Trends in major non-communicable diseases and related risk factors in China 2002-2019: an analysis of nationally representative survey data.2002 - 2019年中国主要非传染性疾病及相关风险因素的趋势：基于全国代表性调查数据的分析
Lancet Reg Health West Pac. 2023 Jun 20;43:100809. doi: 10.1016/j.lanwpc.2023.100809. eCollection 2024 Feb.
2
Tobacco control in China.中国的烟草控制。
Lancet Public Health. 2023 Dec;8(12):e1006-e1015. doi: 10.1016/S2468-2667(23)00242-6.
3
Utilization of Smoking Cessation Support Among Adults - 18 PLADs, China, 2020.中国2020年18个省成年人群戒烟支持的利用情况
China CDC Wkly. 2023 May 26;5(21):459-463. doi: 10.46234/ccdcw2023.087.
4
Utilization and Effectiveness of a Message-Based Tobacco Cessation Program (mCessation) in the Chinese General Population: Longitudinal, Real-world Study.基于信息的戒烟计划（mCessation）在普通中国人群中的使用情况和效果：纵向、真实世界研究。
J Med Internet Res. 2023 May 2;25:e44840. doi: 10.2196/44840.
5
Agreement between the Fagerström test for nicotine dependence (FTND) and the heaviness of smoking index (HSI) for assessing the intensity of nicotine dependence among daily smokers.用于评估每日吸烟者尼古丁依赖强度的尼古丁依赖Fagerström测试（FTND）与吸烟量指数（HSI）之间的一致性。
Tob Induc Dis. 2022 Nov 25;20:105. doi: 10.18332/tid/155376. eCollection 2022.
6
Tobacco smoking and risks of more than 470 diseases in China: a prospective cohort study.中国的烟草使用与 470 多种疾病风险的关系：一项前瞻性队列研究。
Lancet Public Health. 2022 Dec;7(12):e1014-e1026. doi: 10.1016/S2468-2667(22)00227-4.
7
Prevalence of tobacco dependence and associated factors in China: Findings from nationwide China Health Literacy Survey during 2018-19.中国烟草依赖的患病率及相关因素：2018 - 2019年全国中国健康素养调查结果
Lancet Reg Health West Pac. 2022 May 4;24:100464. doi: 10.1016/j.lanwpc.2022.100464. eCollection 2022 Jul.
8
Real-World Utilization and Outcomes of the Veterans Health Administration's Smoking Cessation Text Message Program.退伍军人事务部戒烟短信项目的真实世界利用情况和结果。
Nicotine Tob Res. 2021 May 24;23(6):931-938. doi: 10.1093/ntr/ntaa183.
9
Tobacco dependence should be recognised as a lethal non-communicable disease.烟草依赖应被视为一种致命的非传染性疾病。
BMJ. 2019 May 21;365:l2204. doi: 10.1136/bmj.l2204.
10
Tobacco control and Healthy China 2030.控烟与健康中国 2030.
Tob Control. 2019 Jul;28(4):409-413. doi: 10.1136/tobaccocontrol-2018-054372. Epub 2018 Jul 20.
Zotero 插件